Related references
Note: Only part of the references are listed.Paraoxonase 1 and homocysteine metabolism
Joanna Pera-Kajan et al.
AMINO ACIDS (2012)
Quantitative Assessment of the Influence of Paraoxonase 1 Activity and Coronary Heart Disease Risk
Mingsong Wang et al.
DNA AND CELL BIOLOGY (2012)
Association between PON1 activity and coronary heart disease risk: A meta-analysis based on 43 studies
Yuan Zhao et al.
MOLECULAR GENETICS AND METABOLISM (2012)
Triglycerides and Cardiovascular Disease A Scientific Statement From the American Heart Association
Michael Miller et al.
CIRCULATION (2011)
PON-dering differences in HDL function in coronary artery disease
Chieko Mineo et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease
Christian Besler et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms
Mohamad Navab et al.
NATURE REVIEWS CARDIOLOGY (2011)
Paraoxonase 1 (PON1) deficiency in mice is associated with reduced expression of macrophage SR-BI and consequently the loss of HDL cytoprotection against apoptosis
Bianca Fuhrman et al.
ATHEROSCLEROSIS (2010)
Distribution of C-reactive protein and its association with cardiovascular risk factors in a population-based sample of Chinese
Yanfang Zhao et al.
DISEASE MARKERS (2010)
High-density lipoproteins, inflammation and oxidative stress
Fatiha Tabet et al.
CLINICAL SCIENCE (2009)
Determinants of variation in human serum paraoxonase activity
D. L. Rainwater et al.
HEREDITY (2009)
Paraoxonase-1 deficiency in mice predisposes to vascular inflammation, oxidative stress, and thrombogenicity in the absence of hyperlipidemia
Dominic S. Ng et al.
CARDIOVASCULAR PATHOLOGY (2008)
PON1 status is influenced by oxidative stress and inflammation in coronary heart disease patients
Jelena Kotur-Stevuljevic et al.
CLINICAL BIOCHEMISTRY (2008)
Factors associated with paraoxonase genotypes and activity in a diverse, young, healthy population: The coronary artery risk development in young adults (CARDIA) study
Bharat Thyagarajan et al.
CLINICAL CHEMISTRY (2008)
Protective effect of R allele of PON1 gene on the coronary artery disease in the presence of specific genetic background
Anna Balcerzyk et al.
DISEASE MARKERS (2008)
The role of paraoxonase (PON) enzyme in the extent and severity of the coronary artery disease in type-2 diabetic patients
Zeynep Tartan et al.
HEART AND VESSELS (2007)
Association between paraoxonase activity and lipid levels in patients with premature coronary artery disease
Purnima Dey Sarkar et al.
CLINICA CHIMICA ACTA (2006)
Human paraoxonase-1 overexpression inhibits atherosclerosis in a mouse model of metabolic syndrome
Bharti Mackness et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
High C-reactive protein and low paraoxonase1 in diabetes as risk factors for coronary heart disease
Bharti Mackness et al.
ATHEROSCLEROSIS (2006)
Paraoxonase-1 and serum concentrations of HDL-cholesterol and apoA-I
MCB Garin et al.
JOURNAL OF LIPID RESEARCH (2006)
Macrophage apolipoprotein E reduces atherosclerosis and prevents premature death in apolipoprotein E and scavenger receptor-class BI double-knockout mice
H Yu et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Functionally defective high-density lipoprotein: A new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis
Anatol Kontush et al.
PHARMACOLOGICAL REVIEWS (2006)
The correlation of paraoxonase (PON1) activity with lipid and lipoprotein levels differs with vascular disease status
LS Rozek et al.
JOURNAL OF LIPID RESEARCH (2005)
Mechanisms of disease - Inflammation, atherosclerosis, and coronary artery disease
GK Hansson
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Oxidative stress and vascular disease
NR Madamanchi et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Paraoxonase, a cardioprotective enzyme: continuing issues
GS Getz et al.
CURRENT OPINION IN LIPIDOLOGY (2004)
Serum paraoxonase: effect of the apolipoprotein composition of HDL and the acute phase response
VG Cabana et al.
JOURNAL OF LIPID RESEARCH (2003)
Decreased atherosclerotic lesion formation in human serum paraoxonase transgenic mice
A Tward et al.
CIRCULATION (2002)
Combined serum paraoxonase knockout/apolipoprotein E knockout mice exhibit increased lipoprotein oxidation and atherosclerosis
DM Shih et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
